SIM staff asked
for comment on their most recent policy papers, especially about financing
new services. Concerns were raised that there be no disincentives to
providing innovative new services likely to improve health and save money
including care coordination and medication management. SIM was urged to finance
these promising new services in the same way as promising traditional
treatments. Providers are not asked to pay up front for new drugs that keep
people out of the hospital, nor are the costs of those drugs subtracted from
their shared savings payments. The SIM new services are also expected to improve
value and should not be treated differently than other care. The SIM steering
committee is creating a finance subcommittee to discuss these issues and more. The
group agreed to hear reports on Medicaid’s health neighborhood pilot development
at future meetings.
Note: Independent
consumer advocates also submitted comments to SIM opposing any state of
mind test to enforcement of under service standards.